Home » Stocks » CELU

Celularity, Inc. (CELU)

Stock Price: $9.75 USD 0.25 (2.63%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
After-hours: $9.70 -0.05 (-0.51%) Jul 23, 4:57 PM
Market Cap 201.63M
Revenue (ttm) 16.94M
Net Income (ttm) -290.80M
Shares Out 12.58M
EPS (ttm) -0.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $9.75
Previous Close $9.50
Change ($) 0.25
Change (%) 2.63%
Day's Open 9.56
Day's Range 9.26 - 9.96
Day's Volume 271,915
52-Week Range 7.73 - 13.40

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

The SPAC closed its merger with clinical-stage biotech Celularity.

Other stocks mentioned: GXGX
1 week ago - The Motley Fool

GXGX's merger announcement is causing the stock to soar this afternoon. The SPAC is merging with biotech play Celularity.

Other stocks mentioned: GXGX, PLTR
1 week ago - InvestorPlace

Common stock of the merged company, Celularity, Inc., to commence trading on the Nasdaq Capital Market under the ticker symbol “CELU” on July 19, 2021

Other stocks mentioned: GXGX
1 week ago - GlobeNewsWire

NEW YORK, May 14, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, announced today that its stockholders have voted to approve an a...

Other stocks mentioned: GXGX
2 months ago - PRNewsWire

NEW YORK, May 10, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to amend ...

Other stocks mentioned: GXGX
2 months ago - PRNewsWire

NEW YORK, April 16, 2021 /PRNewswire/ -- On April 14, 2021, GX Acquisition Corp. ("GX") (NASDAQ: "GXGX"), provided information regarding a proposal to amend GX's amended and restated certificate of inco...

Other stocks mentioned: GXGX
3 months ago - PRNewsWire

The stock market has suddenly broken to the downside over the past two weeks. That makes these SPACs particularly risky bets as the momentum fades.

Other stocks mentioned: AGBA, ALUS, CFAC, FAII, GRSV, GXGX
4 months ago - InvestorPlace

About CELU

GX Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2018 and is based in New York, New York.

Industry
Shell Companies
Founded
2016
Stock Exchange
NASDAQ
Ticker Symbol
CELU
Full Company Profile

Financial Performance

In 2020, Celularity's revenue was $14.28 million, a decrease of -32.48% compared to the previous year's $21.15 million. Losses were -$208.23 million, -1.72% less than in 2019.

Financial Statements